In animal models, oxytocin significantly reduced embryo implantation rates, and this was reversed by an oxytocin antagonist. In humans, peptidyl oxytocin and mixed vasopressin V1A/oxytocin antagonists have been found to significantly reduce uterine contractions in egg donors undergoing mock embryo transfer. It has further been demonstrated that the vasopressin V1A/oxytocin receptor antagonist atosiban can improve pregnancy success in patients with recurrent IVF failures.
In your research; that is bovine IVF, oxytocin will only help in sperm motility. Then inside the uterus of the bovine, the oxytocin will negatively affect the implantation of the embryo, so if you will use oxytocin for sperm motility, you have to give oxytocin antagonist to the bovine for proper implantation to take place before transferring the embryos into the bovine.
WE have been depleting moribund sperm with our nano technology. Targeted apoptosis sperm as well as membrane inverted sperm are depleted while Mitochondrial Membrane Potential sperm are enriched,